{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:13:00Z","timestamp":1777587180416,"version":"3.51.4"},"reference-count":15,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>Overlapping central nervous system (CNS) and peripheral nervous system (PNS) demyelination is a rare clinical entity, more frequently seen in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and multiple sclerosis (MS). This case report showcases a patient with atypical CIDP and CNS demyelination lesions. Demographic data, disease course, treatment responsiveness, neurological examination, laboratory tests, nerve conduction studies (NCS), and brain and spinal cord MRI were registered. The case highlights the difficulty of diagnosis establishment and treatment selection, given the atypical course of the disease and limited answers to the indicated therapies. The data from our report suggest that specific and widely available immunological targets are necessary for diagnosing combined central and peripheral demyelination cases appropriately. The association of different immunotherapeutic agents may be necessary to induce and maintain disease remission.<\/jats:p>","DOI":"10.25122\/jml-2022-0010","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:27:56Z","timestamp":1683523676000},"page":"1442-1448","source":"Crossref","is-referenced-by-count":7,"title":["Combined central and peripheral demyelination: a case report"],"prefix":"10.25122","volume":"15","author":[{"name":"Neurology Department No. 1, Nicolae Testemi\u021banu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"* Corresponding Author: Elena Costru-Tasnic, Neurology Department No. 1, Nicolae Testemi\u021banu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova. E-mail: elena.costru@usmf.md","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Costru-Tasnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Manole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Neurology Department No. 1, Nicolae Testemi\u021banu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitalie","family":"Lisnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Neurology Department No. 1, Nicolae Testemi\u021banu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2022,11]]},"reference":[{"key":"ref1","unstructured":"1. Lewis RA. Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis. UpToDate [Internet]. 2018;1\u201322. Available from: https:\/\/www.uptodate.com\/contents\/chronic-inflammatory-demyelinatingpolyneuropathy-etiology-clinical-features-and-diagnosis?search=cidp&source=search_result&selectedTitle=1~47&usage_type=default&display_ rank=1%0Ahttps:\/\/www.uptodate.com\/contents\/chronic-"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Ingwersen J, Graf J, Kluge J, Weise M et al. CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence Tomography. Neurol Neuroimmunol neuroinflammation. 2022;9(1):1\u20139.","DOI":"10.1212\/NXI.0000000000001099"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Cortese A, Franciotta D, Alfonsi E, Visigalli N et al. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment. J Neurol Sci [Internet]. 2016;363:182\u20137. Available from: http:\/\/ dx.doi.org\/10.1016\/j.jns.2016.02.022","DOI":"10.1016\/j.jns.2016.02.022"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Forrester C, Lascelles RG. Association between polyneuritis and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1979;42(9):864\u20136. DOI: 10.1136\/ jnnp.42.9.864","DOI":"10.1136\/jnnp.42.9.864"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Thomas PK, Walker RWH, Rudge P, Morgan-hughes JA et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain. 1987;110(1):53\u201376. DOI: 10.1093\/ brain\/110.1.53","DOI":"10.1093\/brain\/110.1.53"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Oudejans E, Luchicchi A, Strijbis EMM, Geurts JJG, van Dam AM. Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology. Neurol Neuroimmunol neuroinflammation. 2021;8(1). DOI: 10.1212\/ NXI.0000000000000914","DOI":"10.1212\/NXI.0000000000000914"},{"key":"ref7","unstructured":"7. Lisnic V, Gavriliuc M, Odainic O, Misic O, Nemtan V. Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study. Med Cour. 2009;309(3):4\u20137."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Wang YQ, Chen H, Zhuang WP, Li HL. The clinical features of combined central and peripheral demyelination in Chinese patients. J Neuroimmunol [Internet]. 2018;317(88):32\u20136. Available from: https:\/\/doi.org\/10.1016\/j. jneuroim.2018.02.006","DOI":"10.1016\/j.jneuroim.2018.02.006"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Ogata H, Matsuse D, Yamasaki R, Kawamura N et al. A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry. 2016;87(1):29\u201336. DOI: 10.1136\/jnnp-2014-309831","DOI":"10.1136\/jnnp-2014-309831"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Aktas O. Shifting borders, crossing boundaries: The case of combined central and peripheral demyelination. Mult Scler J [Internet]. 2017;24(4):550\u20131. Available from: https:\/\/journals.sagepub.com\/ doi\/10.1177\/1352458517726386","DOI":"10.1177\/1352458517726386"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Pineda AAM, Ogata K, Osoegawa M, Murai H et al. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy. J Neurol Sci. 2007;255(1\u20132):1\u20136. DOI: 10.1016\/j.jns.2007.01.004","DOI":"10.1016\/j.jns.2007.01.004"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2021;143(11):3214\u201324.","DOI":"10.1093\/brain\/awaa265"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Sung JY, Tani J, Park SB, Kiernan MC, Lin CSY. Early identification of \"acute-onset\" chronic inflammatory demyelinating polyneuropathy. Brain. 2014;137(8):2155\u201363.","DOI":"10.1093\/brain\/awu158"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Muley SA, Jacobsen B, Parry G, Usman U et al. Rituximab in refractory chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve. 2020;61(5):575\u20139.","DOI":"10.1002\/mus.26804"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Farag M, Sibtain N, Burge J, Chaudhry V, Silber E. Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement. Mult Scler Relat Disord [Internet]. 2021;51:102926. Available from: https:\/\/doi. org\/10.1016\/j.msard.2021.102926","DOI":"10.1016\/j.msard.2021.102926"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/20.-jml-2022-0010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:28:02Z","timestamp":1683523682000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/20.-jml-2022-0010.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["JMedLife-15-1442"],"URL":"https:\/\/doi.org\/10.25122\/jml-2022-0010","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}